Regarding: Notes & Comments on “Efficacy, safety, and comparison of sonic hedgehog inhibitors in basal cell carcinomas: A systematic review and meta-analysis” - 15/03/22
Doi : 10.1016/j.jaad.2019.04.061
Philippe Lefrançois, MD, PhD ⁎ 
, Pingxing Xie, MD, PhD, Khue H. Nguyen, MD, FRCPC ⁎
, Pingxing Xie, MD, PhD, Khue H. Nguyen, MD, FRCPC ⁎ Division of Dermatology, Department of Medicine, McGill University, Montreal, Quebec, Canada
∗Correspondence to: Philippe Lefrançois, MD, PhD, or Khue H. Nguyen, MD, FRCPC, Division of Dermatology, Montreal General Hospital, 1650 Cedar Ave, Montreal, QC H3G 1A4, CanadaDivision of DermatologyMontreal General Hospital1650 Cedar AveMontrealQCH3G 1A4Canada
Le texte complet de cet article est disponible en PDF.
| Funding sources: This work was partly funded by the Canadian Dermatology Foundation. |
|
| Conflicts of interest: None disclosed. |
© 2019
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 86 - N° 4
P. e157-e158 - avril 2022 Retour au numéro
Article précédent
- Notes & Comments on “Efficacy, safety, and comparison of sonic hedgehog inhibitors in basal cell carcinomas: A systematic review and analysis”
- Meagan Vogt, Anirudh Sethi, Jason Brocato, Nicholas Squittieri
- Assessment of the generalizability of hidradenitis suppurativa microbiome studies: The minimal inclusion of racial and ethnic populations
- Chidubem A.V. Okeke, Raveena Khanna, Ginette A. Okoye, Angel S. Byrd
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?